| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4297a8f4a07110d7735f932692d074a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7997962eb7c52004714b832a0e7449c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ed37ecf43440e1eda9146728216960c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c62fec1d01a3e06bb4bf235064c2c7c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cba14b4a47c59442a16f39859ad4c9d8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465 |
| filingDate |
2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c09d4a605fc88ec674e00bb444e4a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bf3db8c8c9ca446f49183cf8ee73c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c05a136a6fed59b0c23eba363e77309e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_874b78e89c9e1f79fc50c0849ed51213 |
| publicationDate |
2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005051345-A1 |
| titleOfInvention |
Tirofiban for inhalative administration for the treatment of diseases that are caused by thrombosis |
| abstract |
The invention relates to the use of the fibrinogen-IIb/IIIa receptor antagonist tirofiban or one of its derivatives for the prophylaxis and intensive treatment of diseases caused or partly caused by thrombosis. To this end, tirofiban or one of its derivatives is provided in the form of an aerosol that is suitable for inhalative application by means of aerosol generators. After the intrathoracic deposition of the aerosol particles that carry the medicaments, the tirofiban or one of its derivatives passes rapidly into the bloodstream, forming a medicament level that has a prophylactic or therapeutic action. |
| priorityDate |
2003-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |